生产企业：Takeda
Rusfertide is a hepcidin mimetic currently being developed by Protagonist Therapeutics for the treatment of polycythemia vera and beta-thalassemia.
Rusfertide is a hepcidin mimetic currently being developed by Protagonist Therapeutics for the treatment of polycythemia vera and beta-thalassemia.
Hepcidin mimetic. Rusfertide (MIMRYLO) is a first-in-class subcutaneous peptide that mimics the action of hepcidin, the natural hormone regulating iron homeostasis, thereby regulating iron distribution in the body and red blood cell overproduction to control hematocrit levels.
Treatment of erythrocytosis in adults with polycythemia vera (PV)
共 1 项相关疾病
每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。
未检索到以该名称命名的专利
专利文献通常使用化学名或研发代号指代药物，而非通用名；且专利申请在提交约 18 个月后才公开，较新的药物可能尚未出现在这里。
